The Korean Journal of Internal Medicine10.3904/kjim.2016.21420183351016-1024Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapyYoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, Soyoung Won, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Dae-Hyun Yoo, Sang-Cheol Bae,,
Arthritis Care & Research10.1002/acr.22063201365111722-1731Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision AnalysisGlen S. Hazlewood, David Naimark, Michael Gardam, Vivian Bykerk, Claire Bombardier
Intestinal Research10.5217/ir.2014.12.1.12201412112Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor TherapyTae Sun Shim
Arthritis & Rheumatism10.1002/art.2343020085851258-1263Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitorHubert Marotte, Béatrice Arnaud, Jennifer Diasparra, Saloua Zrioual, Pierre Miossec,
Advances in Therapy10.1007/s12325-016-0318-52016335807-823Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid ArthritisZheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, Daniel Chin, Keith A. Betts, Arijit Ganguli,,
Journal of Rheumatic Diseases10.4078/jrd.2015.22.4.2232015224223Incidence of Tuberculosis in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents following Latent Tuberculosis Infection Screening StrategiesYoon-Kyoung Sung, Soo-Kyung Cho, Soyoung Won, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Dae-Hyun Yoo, Sang-Cheol Bae,,
Internal Medicine Journal10.1111/imj.129792016463281-287Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infectionE. L. Gray, H. F. Goldberg
Arthritis & Rheumatology10.1002/art.3958220166861337-1345Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid ArthritisAudrey S. L. Low, Mark Lunt, Louise K. Mercer, Kath D. Watson, William G. Dixon, Deborah P. M. Symmons, Kimme L. Hyrich
Arthritis & Rheumatism10.1002/art.23362200858S2S92-S101Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α,
Value in Health10.1016/j.jval.2012.03.1952012154A34PMS6 Treatment Pattern Visualization of Medicare Patients Diagnosed with Rheumatoid Arthritis and Initiating Tumor Necrosis Factor TherapyO. Baser, L. Wang, L. Xie, H. Yuce,